WalletHub released a new analysis ranking America's most overweight cities, based on obesity rates, health consequences and ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

Shares of Novo Nordisk (NVO) are sliding in Monday trading after the company announces results for its trial of weight-loss drug CagriSema.

Millions of people worldwide suffer from metabolic illnesses, which are largely caused by obesity. In India, 25% of obese adults are at increased risk for cardiac disease, and more than 50% have ...

This discovery may represent a shift from traditional obesity treatments that focus ... and reported no treatment-related adverse effects, suggesting excellent tolerability. Furthermore, Hoth ...

Obesity prevalence increased among both adults and children across all regions of the world from 1990 to 2021, and more than ...

While the reasons for obesity were complex, governments should use the estimates to focus in on how to help populations most at risk. (Image Credits: Pixabay) A new study has revealed that the ...

This, she concluded, "is essential to avoid intergenerational transmission of obesity and to prevent a wave of serious health conditions and dire financial ... pain-relieving effects of cannabis ...

Rates of obesity and overweight are spiralling due to a "monumental societal failure" to tackle the problem, with more than ...